Techno Medical Public Company Limited (TM) fair value: what the stock is really worth
We calculate from audited financials what Techno Medical Public Company Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Techno Medical Public Company Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Techno Medical Public Company Limited, together with its subsidiaries, engages in trading of medical supplies, tools, and equipment in Thailand. The company operates through three segments: Sales of Disposable Equipment and Supplies; Sales of Medical Equipment and Instrument; and Services Relating to Nursing Care.
Show more
Techno Medical Public Company Limited, together with its subsidiaries, engages in trading of medical supplies, tools, and equipment in Thailand. The company operates through three segments: Sales of Disposable Equipment and Supplies; Sales of Medical Equipment and Instrument; and Services Relating to Nursing Care. It also engages in the provision of nursing-care services; and wholesale trading of pharmaceutical products, as well as operates nursing-care school and small parents hospital. It serves medical facilities, including government hospitals, private hospitals, clinics, and medical personnel. The company was incorporated in 2002 and is headquartered in Bangkok, Thailand.
Stock analysis
Techno Medical Public Company Limited (TM) currently trades at 1.31 THB, while our model-based Fair Value estimate is 1.54 THB, implying the stock looks roughly 14.9% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 7.23 THB per share, and 17 of the 23 models we run sit above the 1.31 THB price.
Bear case: the Earnings-Based group reads lowest at 0.7300 THB, and 6 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: 1.14 THB (bear) to 2.15 THB (bull), the price of 1.31 THB sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Techno Medical Public Company Limited reported revenue of 705M THB in FY2025 versus 674M THB in FY2021, a compound +1.1%/yr. Reported net income was 27.5M THB in FY2025, compounding −2.5%/yr from FY2021.
Key figures
Market cap 403M THB (≈ $12.1M) · P/E ratio 14.6 · P/S ratio 0.57 · EPS (TTM) 0.0900 THB · Net margin 3.9% · Return on equity 5.3% · Return on assets (EBIT) 2.7% · Operating margin 7.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades near its 52-week high and 102% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 25% fair-value upside, at 18%, TM screens richer than that median.
Fair Value models
Bear 1.14 THBFair Value 1.54 THBBull 2.15 THB
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0653 THB per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.56/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−7.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−8% vs −17%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 6%
⚠ Revenue per share shrinking 11.7%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Techno Medical Public Company Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 80 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside+25% · Above median
Profitability
Return on equity (TTM)5% · Below median
Return on assets3% · Above median
Net margin (TTM)4% · Above median
Operating margin (TTM)8% · Top 25%
Growth and dividend
Revenue growth7% · Above median
Balance sheet
Debt / equity0.19× · Above median
Valuation Multiplesvs Medical Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Techno Medical Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/TM
Frequently asked questions
Is Techno Medical Public Company Limited (TM) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 1.54 THB versus a price of 1.31 THB, about +18% upside (undervalued).
What is the fair value of TM?
Our model-based fair value for Techno Medical Public Company Limited is 1.54 THB (as of Sep 13, 2026), built from audited fundamentals. The current price: 1.31 THB.
What is the quality score of TM?
Techno Medical Public Company Limited has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Techno Medical Public Company Limited (TM)?
Our model-based price target is the fair value of 1.54 THB (as of Sep 13, 2026) from 23 valuation models. Cautious scenario 1.14 THB, optimistic scenario 2.15 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Techno Medical Public Company Limited stock forecast for 2026?
Our models put fair value at 1.54 THB, about +18% upside versus a price of 1.31 THB (undervalued). Cautious scenario 1.14 THB, optimistic scenario 2.15 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Techno Medical Public Company Limited (TM)?
Techno Medical Public Company Limited reported trailing-twelve-month revenue of about 717M THB (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Techno Medical Public Company Limited (TM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Techno Medical Public Company Limited it is 1.54 THB per share (as of Sep 13, 2026), against a price of 1.31 THB. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Techno Medical Public Company Limited stock overvalued or undervalued in 2026?
As of Sep 13, 2026, TM trades below its calculated fair value: price 1.31 THB, fair value 1.54 THB, a gap of about +18% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TM?
No. The price is what the market pays today (1.31 THB); the fair value is what the company's own numbers justify (1.54 THB). For Techno Medical Public Company Limited the two are 0.2300 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Techno Medical Public Company Limited worth?
The market values Techno Medical Public Company Limited at about 403M THB (market capitalisation, as of Sep 13, 2026). Per share that is 1.31 THB; our models calculate a fair value of 1.54 THB per share.
What do the bullish and bearish scenarios say about TM?
Our models span a range for Techno Medical Public Company Limited: cautious scenario 1.14 THB, base 1.54 THB, optimistic 2.15 THB per share (as of Sep 13, 2026, price 1.31 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TM?
Techno Medical Public Company Limited trades at a price-to-earnings ratio of 14.6 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.54 THB is built from several models across several years. Other multiples: P/B 0.7, P/S 0.4, EV/EBITDA 4.3.
How solid is the balance sheet of Techno Medical Public Company Limited (TM)?
Balance-sheet figures for Techno Medical Public Company Limited (as of Sep 13, 2026): return on equity 5.3%, debt of 0.19 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is TM from its 52-week high?
Techno Medical Public Company Limited trades at 1.31 THB, about 11% below its 52-week high of 1.18 THB and 102% above the low of 0.6500 THB (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 1.54 THB is for.
Which stocks are comparable to Techno Medical Public Company Limited?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Techno Medical Public Company Limited stock attractive at the current price?
The data as of Sep 13, 2026: price 1.31 THB, calculated fair value 1.54 THB (+18%), Quality Score 70/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TM calculated?
We run Techno Medical Public Company Limited through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.54 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. Techno Medical Public Company Limited currently trades 18 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Techno Medical Public Company Limited (TM)?
The closing price on Sep 21, 2026 was 1.31 THB. Our model-based fair value is 1.54 THB, about +18% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Techno Medical Public Company Limited right now?
A fairly wide model range (1.14 THB to 2.15 THB) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Techno Medical Public Company Limited
How large is the market capitalisation of Techno Medical Public Company Limited (TM)?
The market capitalisation of Techno Medical Public Company Limited is 403M THB (≈ $12.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Techno Medical Public Company Limited (TM)?
The price-to-sales ratio of Techno Medical Public Company Limited is 0.57 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Techno Medical Public Company Limited (TM)?
Earnings per share at Techno Medical Public Company Limited are 0.0900 THB (price ÷ EPS = P/E 14.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Techno Medical Public Company Limited (TM)?
The net margin of Techno Medical Public Company Limited is 3.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Techno Medical Public Company Limited (TM)?
The return on equity (ROE) of Techno Medical Public Company Limited is 5.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Techno Medical Public Company Limited (TM)?
On an EBIT basis the return on assets of Techno Medical Public Company Limited is 2.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Techno Medical Public Company Limited (TM)?
The operating margin of Techno Medical Public Company Limited is 7.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Techno Medical Public Company Limited (TM)?
Revenue at Techno Medical Public Company Limited is growing +6.6% versus a year earlier (3y avg +3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Techno Medical Public Company Limited (TM)?
Earnings per share at Techno Medical Public Company Limited are growing +20.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Techno Medical Public Company Limited (TM) generate?
The free cash flow of Techno Medical Public Company Limited is 430M THB (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Techno Medical Public Company Limited (TM) carry?
The net debt of Techno Medical Public Company Limited is 289M THB (fiscal year 2025, ≈ 0.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Techno Medical Public Company Limited in the live analysis
One click puts Techno Medical Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
